COVID-19 and Fake News in the Dominican Republic.
Antibodies, Monoclonal, Humanized
/ therapeutic use
Antiviral Agents
/ supply & distribution
Azithromycin
/ supply & distribution
Betacoronavirus
/ drug effects
COVID-19
Civil Disorders
Coronavirus Infections
/ drug therapy
Dissent and Disputes
Dominican Republic
/ epidemiology
Drug Repositioning
Humans
Hydroxychloroquine
/ supply & distribution
Ivermectin
/ supply & distribution
Pandemics
/ economics
Pneumonia, Viral
/ drug therapy
Politics
Public Health
/ economics
SARS-CoV-2
Social Media
/ ethics
Trust
/ psychology
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
pubmed:
3
5
2020
medline:
17
6
2020
entrez:
3
5
2020
Statut:
ppublish
Résumé
The first case of novel coronavirus disease (COVID-19) in the Dominican Republic coincided with a period of political crisis. Distrust in governmental institutions shaped the critical phase of early response. Having a weak public health infrastructure and a lack of public trust, the Ministry of Health (MoH) began the fight against COVID-19 with a losing streak. Within 45 days of the first reported case, the political crisis and turmoil caused by "fake news" are limiting the capacity and success of the MoH response to the pandemic.
Identifiants
pubmed: 32358952
doi: 10.4269/ajtmh.20-0234
pmc: PMC7253109
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
Antiviral Agents
0
Hydroxychloroquine
4QWG6N8QKH
Ivermectin
70288-86-7
Azithromycin
83905-01-5
tocilizumab
I031V2H011
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1172-1174Références
J Travel Med. 2020 May 18;27(3):
pubmed: 32181488
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265005